These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3296635)

  • 21. Isolated human growth hormone deficiency due to the hGH-I gene deletion with (type IA) and without (the Israeli-type) hGH antibody formation during hGH therapy.
    Nishi Y; Masuda H; Nishimura S; Kihara M; Suwa S; Tachibana K; Takeda M; Okada Y; Matsuda I
    Acta Endocrinol (Copenh); 1990 Feb; 122(2):267-71. PubMed ID: 1969217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human growth hormone produced with recombinant DNA technology: development and production.
    Flodh H
    Acta Paediatr Scand Suppl; 1986; 325():1-9. PubMed ID: 3296632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Turner's syndrome: treatment of 203 patients with recombinant human growth hormone for one year. A multicentre study.
    Takano K; Shizume K; Hibi I
    Acta Endocrinol (Copenh); 1989 May; 120(5):559-68. PubMed ID: 2658450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of pituitary dwarfism with recombinant human growth hormone. A multicenter study].
    Bierich JR; Ranke MB; Beyer P; Bittner P; Borkenstein H; Brämswig J; Butenandt O; Kollmann F; Stöver B; Schweikert HU
    Dtsch Med Wochenschr; 1986 Mar; 111(13):483-9. PubMed ID: 3514193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of subcutaneous and intramuscular administration of human growth hormone (hGH) and increased growth rate by daily injection of hGH in GH deficient children.
    Takano K; Shizume K; Hibi I
    Endocrinol Jpn; 1988 Jun; 35(3):477-84. PubMed ID: 3197659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A screening test to detect HGH-antibodies in pituitary dwarfs treated with HGH preparation by the radio-immunoassay with double antibody technique.
    Okada Y; Takahashi T; Kumahara Y
    Endocrinol Jpn; 1977 Dec; 24(6):589-93. PubMed ID: 606547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accelerated growth following treatment of children with chronic renal failure with recombinant human growth hormone (somatrem): a preliminary report.
    Lippe B; Fine RN; Koch VH; Sherman BM
    Acta Paediatr Scand Suppl; 1988; 343():127-31. PubMed ID: 3057804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of the treatment of growth hormone deficiency with methionine-somatotropin or recombinant somatotropin].
    Dorantes-Alvarez LM
    Bol Med Hosp Infant Mex; 1990 Jun; 47(6):369-71. PubMed ID: 2222818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of anti-hGH antibody analysis].
    Takano K
    Nihon Rinsho; 1990 Feb; 48 Suppl():861-3. PubMed ID: 2355625
    [No Abstract]   [Full Text] [Related]  

  • 30. Present situation worldwide regarding the use and clinical experience of Somatonorm (somatrem).
    Flodh H
    Acta Paediatr Scand Suppl; 1987; 331():1-4. PubMed ID: 3300150
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of growth hormone on short normal children.
    Hindmarsh PC; Brook CG
    Br Med J (Clin Res Ed); 1987 Sep; 295(6598):573-7. PubMed ID: 3117236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reactivity of peripheral blood lymphocytes in children with pituitary dwarfism treated with human growth hormone (author's transl)].
    Kunicka A; Lenartowska I; Sielicka M
    Probl Med Wieku Rozwoj; 1975; 5():155-60. PubMed ID: 1223865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy in dwarfism. Use of genetically produced growth hormone in practice].
    Neugebauer M
    Med Monatsschr Pharm; 1986 Nov; 9(11):345-6. PubMed ID: 3543630
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current status of the growth hormone therapy in dwarfism].
    Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1984 Dec; 60(12):1492-502. PubMed ID: 6529990
    [No Abstract]   [Full Text] [Related]  

  • 35. Knemometry as a predictor of response to somatrem in Turner's syndrome.
    Wales JK; Milner RD
    Acta Paediatr Scand Suppl; 1987; 337():37-9. PubMed ID: 3481183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial with somatonorm in idiopathic growth hormone deficiency in children.
    Shi YF; Liu R; Bao XL; Deng JY; Gunnarsson R
    Chin Med J (Engl); 1990 Jun; 103(6):470-7. PubMed ID: 2119959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant DNA produced somatropin in the treatment of prepubertal growth hormone deficient children.
    Chang TC; Kuo HF; Liu PC; Shih KC; Zeisel HJ; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jan; 47(1):7-12. PubMed ID: 1848467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of 80 patients with Turner's syndrome with recombinant human growth hormone (YM-17798) for one year: the results of a multicentric study in Japan. Committee for the Treatment of Turner's Syndrome.
    Takano K; Shizume K; Hibi I
    Endocrinol Jpn; 1989 Apr; 36(2):253-60. PubMed ID: 2673750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term treatment with human growth hormone (Raben) in small doses. Evaluation of 18 hypopituitary patients.
    Prader A; Zachmann M; Poley JR; Illig R; Széky J
    Helv Paediatr Acta; 1967 Oct; 22(5):423-40. PubMed ID: 5595745
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of pituitary dwarfism with human somatotropin].
    Rath F; Waldhäusl W
    Wien Klin Wochenschr; 1971 Sep; 83(38):665-8. PubMed ID: 5096738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.